Journal of Medicinal Chemistry · 2011 · 54 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyGlucagon-like Peptide-1 Receptor AgonistsLigand BindingPeptide ChemistryPeptide Drug DiscoveryReceptor PharmacologyReceptor-ligand InteractionsGlp-1 Receptor PharmacologyGlucagon Receptor AgonistsGlucagon-like Peptide 1 Receptor AgonismGlucagon-like Peptide-1 Receptor SignalingGlucagon-like PeptidesPeptide Analogue DesignReporter Gene AssaysSmall-molecule Glp-1 Receptor Agonists
A novel cyclobutane class of nonpeptidic glucagon-like peptide-1 (GLP-1) receptor agonists, exemplified by 3, was identified using receptor binding and multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assays. The structures of 3 and its three isomers were elucidated by NMR, HRESIMS, and X-ray crystallography. A series of structural modifications were also made based on the core structure of 3 with different substitution groups at the west and east ends. Among these analogues, compound 16 was found to be 4- to 5-fold more potent than 3 both in vitro and in vivo.
23
Yazhou Li, TracyAnn Perry, Mark S. Kindy et al. · Proceedings of the National Academy of Sciences · 2009 · 576 citations · Full text
Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes
Julio Rosenstock, Michelle A. Baron, S. Dejager et al. · Diabetes Care · 2007 · 271 citations · Full text